Follow
Heidi Noels
Heidi Noels
Institute for Molecular Cardiovascular Research
Verified email at ukaachen.de
Title
Cited by
Cited by
Year
Atherosclerosis: current pathogenesis and therapeutic options
C Weber, H Noels
Nature medicine 17 (11), 1410-1422, 2011
25572011
Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection
A Zernecke, K Bidzhekov, H Noels, E Shagdarsuren, L Gan, B Denecke, ...
Science signaling 2 (100), ra81-ra81, 2009
15762009
MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1
A Schober, M Nazari-Jahantigh, Y Wei, K Bidzhekov, F Gremse, ...
Nature medicine 20 (4), 368-376, 2014
6682014
MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages
M Nazari-Jahantigh, Y Wei, H Noels, S Akhtar, Z Zhou, RR Koenen, ...
The Journal of clinical investigation 122 (11), 4190-4202, 2012
5722012
The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease
Y Döring, L Pawig, C Weber, H Noels
Frontiers in physiology 5, 88349, 2014
3262014
Diversity and inter-connections in the CXCR4 chemokine receptor/ligand family: molecular perspectives
L Pawig, C Klasen, C Weber, J Bernhagen, H Noels
Frontiers in immunology 6, 156039, 2015
2142015
The dark side of EGFP: defective polyubiquitination
M Baens, H Noels, V Broeckx, S Hagens, S Fevery, AD Billiau, ...
PloS one 1 (1), e54, 2006
2072006
Platelet microparticles reprogram macrophage gene expression and function
B Laffont, A Corduan, M Rousseau, AC Duchez, CHC Lee, E Boilard, ...
Thrombosis and haemostasis 115 (02), 311-323, 2016
1822016
Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-κB activation
S Rosebeck, L Madden, X Jin, S Gu, IJ Apel, A Appert, RA Hamoudi, ...
science 331 (6016), 468-472, 2011
1772011
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting
J Soppert, M Lehrke, N Marx, J Jankowski, H Noels
Advanced drug delivery reviews 159, 4-33, 2020
1682020
Vascular CXCR4 limits atherosclerosis by maintaining arterial integrity: evidence from mouse and human studies
Y Döring, H Noels, EPC Van Der Vorst, C Neideck, V Egea, M Drechsler, ...
Circulation 136 (4), 388-403, 2017
1642017
Arrest functions of the MIF ligand/receptor axes in atherogenesis
S Tillmann, J Bernhagen, H Noels
Frontiers in immunology 4, 115, 2013
1482013
The pathogenesis of MALT lymphomas: where do we stand?
X Sagaert, D Wolf-Peeters, H Noels, M Baens
Leukemia 21 (3), 389-396, 2007
1372007
Chemokines as therapeutic targets in cardiovascular disease: the road behind, the road ahead
H Noels, C Weber, RR Koenen
Arteriosclerosis, Thrombosis, and Vascular Biology 39 (4), 583-592, 2019
1152019
A novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-κB activation by API2· MALT1 fusions
H Noels, G van Loo, S Hagens, V Broeckx, R Beyaert, P Marynen, ...
Journal of biological chemistry 282 (14), 10180-10189, 2007
1092007
Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis
H Noels, J Bernhagen, C Weber
Trends in cardiovascular medicine 19 (3), 76-86, 2009
1002009
Atheroprotective mechanisms of shear stress-regulated microRNAs
RA Boon, E Hergenreider, S Dimmeler
Thrombosis and haemostasis 108 (10), 616-620, 2012
992012
Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations
H Noels, M Lehrke, R Vanholder, J Jankowski
Nature Reviews Nephrology 17 (8), 528-542, 2021
872021
Selective expansion of marginal zone B cells in Eμ-API2-MALT1 mice is linked to enhanced IκB kinase γ polyubiquitination
M Baens, S Fevery, X Sagaert, H Noels, S Hagens, V Broeckx, AD Billiau, ...
Cancer research 66 (10), 5270-5277, 2006
812006
Deficiency of Endothelial Cxcr4 Reduces Reendothelialization and Enhances Neointimal Hyperplasia After Vascular Injury in Atherosclerosis-Prone Mice
H Noels, B Zhou, PV Tilstam, W Theelen, X Li, L Pawig, C Schmitz, ...
Arteriosclerosis, thrombosis, and vascular biology 34 (6), 1209-1220, 2014
742014
The system can't perform the operation now. Try again later.
Articles 1–20